))
Therapy Unblinded: Inside MDMA Research Part 2
Manage episode 430825026 series 2818467
Contenuto fornito da Windrose Recovery. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Windrose Recovery o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Dr. Chantelle Thomas and Dr. Ingmar Gorman discuss the safety and ethical considerations of MDMA-assisted psychotherapy for PTSD, including standardization, non-directive approach, and adherence to therapy protocol. They also explore complex power dynamics in therapeutic relationships, ethical nuances of supporting participants in psychedelic studies, and the importance of representing a diverse population in psychedelic trials.
(00:00:00) Introduction
(00:10:30) Therapist-participant relationships in psychedelic-assisted therapy trial.
(00:14:58) Challenges in supporting participants in psychedelic studies after the end of the trial.
(00:23:11) Standardizing therapy for MDMA-assisted therapy trial.
(00:32:11) The importance of non-directional support.
(00:36:37) Operationalizing therapy techniques to ensure consistency and address power imbalances.
(00:43:06) Psychedelic therapy adherence and rating systems.
(00:50:08) Therapist flexibility in the trial.
(00:59:41) Inclusion of diverse participants.
Dr. Chantelle Thomas, Executive Clinical Director Windrose Recovery: https://windroserecovery.com/
Integrata: www.integratahealing.com
Dr. Ingmar Gorman: https://www.ingmargorman.com/about
Lykos: https://lykospbc.com
35 episodi
Condividi
